Core Biogenesis Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
31
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
16
Core Biogenesis General Information
Description
Developer of bioproduction technologies designed to use plants as biofactories to scale the production of valued bioproducts. The company's platform accelerates mass production and isolates molecules to a specific plant compartment, making extraction scalable and offering proprietary gene editing and plant biotechnology to produce growth factor molecules used in the clean meat and cell, enabling healthcare professionals to regulate the growth, division, and survival of cells, increase yields, and reduce costs.
Contact Information
Website
www.corebiogenesis.comCorporate Office
- 8C rue Schertz
- Parc Phoenix
- 67100 Strasbourg
- France
Corporate Office
- 8C rue Schertz
- Parc Phoenix
- 67100 Strasbourg
- France
Core Biogenesis Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Accelerator/Incubator | 04-Apr-2023 | Completed | Generating Revenue | |||
| 7. Accelerator/Incubator | 06-May-2022 | Completed | Generating Revenue | |||
| 6. Early Stage VC (Series A) | 29-Mar-2022 | Completed | Generating Revenue | |||
| 5. Grant | 23-Mar-2022 | Completed | Startup | |||
| 4. Accelerator/Incubator | 01-Jan-2021 | Completed | Startup | |||
| 3. Seed Round | 08-Dec-2020 | Completed | Startup | |||
| 2. Accelerator/Incubator | 01-Jan-2020 | Completed | Startup | |||
| 1. Accelerator/Incubator | 01-Jan-2020 | Completed | Startup |
Core Biogenesis Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Core Biogenesis Comparisons
Industry
Financing
Details
Core Biogenesis Competitors (2)
One of Core Biogenesis’s 2 competitors is Univercells Technologies, a Corporate Backed or Acquired company based in Nivelles, Belgium.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Univercells Technologies | Corporate Backed or Acquired | Nivelles, Belgium | ||||
| NanoTemper Technologies | Corporation | Munich, Germany |
Core Biogenesis Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Core Biogenesis Patents
Core Biogenesis Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026027990-A1 | Bioactive growth factors for dermal topical applications | Pending | 30-Jul-2024 | ||
| EP-4190905-A1 | Method for the purification of recombinant proteins using oil body proteins | Inactive | 01-Dec-2021 | ||
| US-20250042938-A1 | Method for the purification of recombinant proteins using oil body proteins | Pending | 01-Dec-2021 | ||
| WO-2023099644-A1 | Method for the purification of recombinant proteins using oil body proteins | Inactive | 01-Dec-2021 | ||
| CA-3212320-A1 | A genetically engineered plant or part thereof adapted for the production of recombinant proteins and process thereof | Pending | 16-Mar-2021 | C12N15/8218 |
Core Biogenesis Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Core Biogenesis Investors (16)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| La French Tech Est | Accelerator/Incubator | |||
| SEMIA Incubateur d' Alsace | Accelerator/Incubator | |||
| Blue Horizon Corporation | Venture Capital | Minority | ||
| ByTheTower | Venture Capital | Minority | ||
| GG 1978 | Venture Capital | Minority |
Core Biogenesis FAQs
-
When was Core Biogenesis founded?
Core Biogenesis was founded in 2020.
-
Where is Core Biogenesis headquartered?
Core Biogenesis is headquartered in Strasbourg, France.
-
What is the size of Core Biogenesis?
Core Biogenesis has 31 total employees.
-
What industry is Core Biogenesis in?
Core Biogenesis’s primary industry is Biotechnology.
-
Is Core Biogenesis a private or public company?
Core Biogenesis is a Private company.
-
What is Core Biogenesis’s current revenue?
The current revenue for Core Biogenesis is .
-
How much funding has Core Biogenesis raised over time?
Core Biogenesis has raised $14.2M.
-
Who are Core Biogenesis’s investors?
La French Tech Est, SEMIA Incubateur d' Alsace, Blue Horizon Corporation, ByTheTower, and GG 1978 are 5 of 16 investors who have invested in Core Biogenesis.
-
Who are Core Biogenesis’s competitors?
Univercells Technologies and NanoTemper Technologies are competitors of Core Biogenesis.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
